Investigating FE 202158 as Potential Primary Treatment in Patients With Early Septic Shock
Clinical trial NCT01612676 · COMPLETED
Trial details
- NCT number
- NCT01612676
- Sponsor
- Ferring Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2013-11-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.